
Share on:
Mobelife and JRI Orthopaedics will collaborate to grow Mobelife’s aMace® Acetabular Revision System business further in the UK and Ireland. aMace is designed to offer complete personalization to both patient and surgeon.
Mobelife’s solution for hip revisions will join JRI’s lower limb portfolio, a range of implants and instruments including the Furlong hip stem. Mobelife, part of the Materialise Group, offers a completely customized product development process for patient-specific orthopaedic implants.
Source: Mobelife NV
RELATED ARTICLES
Sandvik to Divest Additive Manufacturing Business Unit
Jun 16 2026 , Julie A. Vetalice
Cretex Medical Acquires Select Assets and Capabilities of Holland Molds
Jun 16 2026 , Julie A. Vetalice
Medical Component Specialists Appoints President & CEO
Jun 15 2026 , Julie A. Vetalice



